Study shows kidney drug can boost treatment outcomes for heart attack patients
An international team of researchers, led by one of Indian origin, has demonstrated that a drug used to treat kidney diseases can be safely administered to patients who are hospitalised for acute myocardial infarction -- heart attack.
The team led by Mount Sinai Fuster Heart Hospital demonstrated that the drug empagliflozin can reliably lower heart failure episodes in individuals who have had a heart attack, regardless of the patient`s pre-existing renal function.
Acute heart attack patients are particularly vulnerable to acute renal injury because of prolonged exposure to kidney stressors, such as diuretics or contrast agents used during cardiac catheterisation.
Because of this danger, doctors are hesitant to start empagliflozin soon after a heart attack because there is little data r...










